J. A. Roberts

H. I. Jensen1
J. Bakker1
T. Pham1
L. C. Chiu1
B. Maghsudi1
1H. I. Jensen
1J. Bakker
1T. Pham
1L. C. Chiu
1B. Maghsudi
Learn More
Piperacillin-tazobactam is frequently used for empirical and targeted therapy of infections in critically ill patients. Considerable pharmacokinetic (PK) variability is observed in critically ill patients. By estimating an individual's PK, dosage optimization Bayesian estimation techniques can be used to calculate the appropriate piperacillin regimen to(More)
In the context of globally increasing antimicrobial resistance, tigecycline appears to be a useful therapeutic option. The need for prolonged courses for complex infections has prompted consideration of its use via outpatient parenteral antibiotic therapy (OPAT) programmes, although clinical outcomes when used in this setting remain unknown. We(More)
  • 1